General Information of the Compound
| Compound ID |
CP0039381
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-2-Amino-N-((S)-1-carbamoyl-2-phenyl-ethyl)-3-phenyl-propionamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
(S)-2-Amino-N-((S)-1-carbamoyl-2-phenyl-ethyl)-3-phenyl-propionamide
15893-46-6
AC1L38WX
BDBM50188489
CHEMBL108438
H-Phe-Phe-NH2
L-Phe-L-Phe-NH2
L-Phe-L-phe-amide
L-Phenylalaninamide, L-phenylalanyl-
L-Phenylalanine-L-phenylalanylamide
Phe-phe-amide
Phenylalanylphenylalanylamide
XXPXQEQOAZMUDD-HOTGVXAUSA-N
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H21N3O2
|
||||||||||||||||||
| Molecular Weight |
311.385
|
||||||||||||||||||
| Canonical SMILES |
N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H21N3O2/c19-15(11-13-7-3-1-4-8-13)18(23)21-16(17(20)22)12-14-9-5-2-6-10-14/h1-10,15-16H,11-12,19H2,(H2,20,22)(H,21,23)/t15-,16-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
XXPXQEQOAZMUDD-HOTGVXAUSA-N
|
||||||||||||||||||
| CAS |
15893-46-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound